A smaller subset of CD19+CD20+TBX21+ITGAX+ cells (ABC 2) from people with eMS (~0.3% of B cells) that exhibited surprisingly broad immune lineage expression and pro-inflammatory cytokine transcripts was also underrepresented in people without subsequent disease activity after baseline. The gene discussed is CD19; the disease is eosinophilia-myalgia syndrome.